United States · FDA National Drug Code directory
Trumenba
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0005-0100_81783d36-a13f-4075-9962-8f45a9859b97
- Product NDC
- 0005-0100
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- meningococcal group B vaccine
- Labeler
- Wyeth Pharmaceutical Division of Wyeth Holdings LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20141105
- Source listing expiry
- 20271231
Source-listed ingredients
- NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN — 60 ug/.5mL
- NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN — 60 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 SYRINGE in 1 CARTON (0005-0100-05) / .5 mL in 1 SYRINGE (0005-0100-01) · 0005-0100-05
- 10 SYRINGE in 1 CARTON (0005-0100-10) / .5 mL in 1 SYRINGE (0005-0100-01) · 0005-0100-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →